Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer
Journal of Clinical OncologyPublished 1 January 2002
A Depierre
Citations438
SJR quartileQ1
SJR score11.21
SNIP5.98
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Although impressive differences in median, 3-year, and 4-year survival were observed, they were not statistically significant, except for stage I and II disease.
Abstract
Although impressive differences in median, 3-year, and 4-year survival were observed, they were not statistically significant, except for stage I and II disease.
Keywords
Medicine
Springer series in statisticsNonparametric Estimation from Incomplete Observations
45,533 Citations1992Edward L. Kaplan, Paul Meier
CA A Cancer Journal for CliniciansCancer statistics, 1997
2,026 Citations1997Paul Park, T. Tong +2 more
CHEST JournalA New International Staging System for Lung Cancer
1,665 Citations1986Clifton F. Mountain
The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups that relate to patient management and prognosis and can be readily applied in a broad spectrum of clinical and teaching environments.
PubMedA mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.
1,340 Citations1980Goldie Jh, Coldman Aj
Analysis of the model indicates that the probability of the appearance of a resistant phenotype increases with the mutation rate, and for any population of tumors with a non-zero mutation rate the likelihood of there being at least one resistant cell will go from a condition of low to high probability over a very short interval in the tumor's biologic history.
New England Journal of MedicineA Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
1,264 Citations1994R. Rosell, José Gómez‐Codina +13 more
Preoperative chemotherapy increases the median survival in patients with non-small-cell lung cancer, and the prevalence of mutated K-ras oncogenes was 15 percent among the patients receiving preoperative chemotherapy and 42 percent among those treated with surgery alone.
JNCI Journal of the National Cancer InstituteA Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
1,117 Citations1994Jack A. Roth, Frank V. Fossella +10 more
This clinical trial strengthens the validity of using perioperative chemotherapy in the management of patients with resectable stage IIIA non-small-cell lung cancer by suggesting that survival is improved when compared with treatment by surgery alone.
Journal of Thoracic and Cardiovascular SurgeryModern thirty-day operative mortality for surgical resections in lung cancer
654 Citations1983Robert J. Ginsberg, Lucius D. Hill +12 more
The striking similarity of postoperative mortality rates for resectional operations for lung cancer among the various centers of the LCSG and among theVarious institutions within these centers suggest that these data are a reasonably accurate analysis of modern surgical mortality rates in the treatment of lung cancer.
Lung CancerLong-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
449 Citations1998Jack A. Roth, E. Neely Atkinson +9 more
The increase in survival conferred by perioperative chemotherapy was maintained during the period of extended observation, and the median time from random allocation to analysis for all patients of 82 months was 82 months.
Surgical Clinics of North AmericaThe Role of Surgery in N2 Lung Cancer
428 Citations1987Nael Martini, Betty J. Flehinger
Data is presented to support the view that a significant number of patients with mediastinal lymph node metastases do have resectable tumors with encouraging long-term survival results and steps identified to guide the physicians in selecting the patients who can benefit from this surgical approach.
Lung CancerPreresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
396 Citations1999Rafael Rosell, José Gómez‐Codina +7 more
The Annals of Thoracic SurgeryRandomized trial of neoadjuvant therapy for lung cancer: Interim analysis
333 Citations1992Harvey I. Pass, Helen W. Pogrebniak +3 more
This interim analysis demonstrates the feasibility of such a trial and suggests a trend toward increased survival time for the EP group versus the SRT group, but despite the trends, definitive conclusions await further accrual and study maturation.
The Annals of Thoracic SurgeryThe Importance of Surgery to Non-Small Cell Carcinoma of Lung with Mediastinal Lymph Node Metastasis
306 Citations1988Tsuguo Naruke, Tomoyuki Goya +2 more
A comparative study has been made of 5-year survival of patients who had pulmonary resection with and without mediastinal lymph node dissection of patients with N2 M0 disease.
JNCI Journal of the National Cancer InstituteSigniicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma
261 Citations1992Thierry Le Chevalier, R. Arriagada +7 more
Journal of Thoracic and Cardiovascular SurgeryInduction chemotherapy before surgery for early-stage lung cancer: A novel approach
238 Citations2000K. M. W. Pisters, Robert J. Ginsberg +8 more
Induction chemotherapy with paclitaxel and carboplatin is feasible and produces a high response rate with acceptable morbidity and mortality rates in early-stage non-small cell lung carcinoma.
Seminars in Surgical OncologySurgical treatment of non‐small cell lung cancer by stage
55 Citations1990Nael Martini
Surgery is of very limited value in Patients with tumors invading the mediastinum and in patients with stage IIIb or stage IV disease, soection alone or combined with radiation and/or chemotherapy is also indicated in some patients withStage IIIa disease.
American Review of Respiratory DiseaseCritical Analysis of Neoadjuvant Therapy for State Illa Non-Small Cell Lung Cancer
28 Citations1991John R. Murren, Antônio C. Buzaid +1 more
The role of neoadjuvant treatment for locally advanced lung cancer will not be known until properly designed randomized trials are conducted, and preliminary trials have shown that this approach is feasible.
Surgical Oncology Clinics of North AmericaThe Role of Multimodality Therapy in Locoregional Non-small Cell Lung Cancer
26 Citations1997Nael Martini, Mark G. Kris +1 more
Induction therapy on an investigational basis is recommended to most patients with stage I or II tumors and to all those with stage IIIA tumors, when the 5 year survival is anticipated to be less than 50% with conventional therapy.
New England Journal of MedicineChemotherapy plus Surgery versus Surgery Alone in Non-Small-Cell Lung Cancer
9 Citations1994V. Cocquyt, Wilfried De Neve +1 more